nodes	percent_of_prediction	percent_of_DWPC	metapath
Triamterene—SCNN1A—Stimuli-sensing channels—TRPM7—Parkinson's disease	0.0523	0.0652	CbGpPWpGaD
Triamterene—SCNN1B—Stimuli-sensing channels—TRPM7—Parkinson's disease	0.0523	0.0652	CbGpPWpGaD
Triamterene—SCNN1D—Stimuli-sensing channels—TRPM7—Parkinson's disease	0.0523	0.0652	CbGpPWpGaD
Triamterene—SCNN1G—Stimuli-sensing channels—TRPM7—Parkinson's disease	0.0523	0.0652	CbGpPWpGaD
Triamterene—SCNN1A—Ion channel transport—ATP1A3—Parkinson's disease	0.0341	0.0425	CbGpPWpGaD
Triamterene—SCNN1G—Ion channel transport—TRPM7—Parkinson's disease	0.0341	0.0425	CbGpPWpGaD
Triamterene—SCNN1G—Ion channel transport—ATP1A3—Parkinson's disease	0.0341	0.0425	CbGpPWpGaD
Triamterene—SCNN1B—Ion channel transport—TRPM7—Parkinson's disease	0.0341	0.0425	CbGpPWpGaD
Triamterene—SCNN1D—Ion channel transport—ATP1A3—Parkinson's disease	0.0341	0.0425	CbGpPWpGaD
Triamterene—SCNN1B—Ion channel transport—ATP1A3—Parkinson's disease	0.0341	0.0425	CbGpPWpGaD
Triamterene—SCNN1D—Ion channel transport—TRPM7—Parkinson's disease	0.0341	0.0425	CbGpPWpGaD
Triamterene—SCNN1A—Ion channel transport—TRPM7—Parkinson's disease	0.0341	0.0425	CbGpPWpGaD
Triamterene—SCNN1D—forebrain—Parkinson's disease	0.0284	0.152	CbGeAlD
Triamterene—SCNN1D—head—Parkinson's disease	0.0163	0.087	CbGeAlD
Triamterene—SCNN1D—nervous system—Parkinson's disease	0.0154	0.0825	CbGeAlD
Triamterene—SCNN1D—central nervous system—Parkinson's disease	0.0148	0.0794	CbGeAlD
Triamterene—SCNN1D—cerebellum—Parkinson's disease	0.0145	0.0776	CbGeAlD
Triamterene—SCNN1G—cerebellum—Parkinson's disease	0.0145	0.0776	CbGeAlD
Triamterene—SCNN1B—head—Parkinson's disease	0.0137	0.0735	CbGeAlD
Triamterene—SCNN1B—nervous system—Parkinson's disease	0.013	0.0697	CbGeAlD
Triamterene—SCNN1A—head—Parkinson's disease	0.0127	0.0679	CbGeAlD
Triamterene—SCNN1B—central nervous system—Parkinson's disease	0.0125	0.0671	CbGeAlD
Triamterene—SCNN1A—Transmembrane transport of small molecules—ATP1A3—Parkinson's disease	0.0119	0.0148	CbGpPWpGaD
Triamterene—SCNN1D—Transmembrane transport of small molecules—ATP1A3—Parkinson's disease	0.0119	0.0148	CbGpPWpGaD
Triamterene—SCNN1B—Transmembrane transport of small molecules—ATP1A3—Parkinson's disease	0.0119	0.0148	CbGpPWpGaD
Triamterene—SCNN1A—Transmembrane transport of small molecules—TRPM7—Parkinson's disease	0.0119	0.0148	CbGpPWpGaD
Triamterene—SCNN1B—Transmembrane transport of small molecules—TRPM7—Parkinson's disease	0.0119	0.0148	CbGpPWpGaD
Triamterene—SCNN1G—Transmembrane transport of small molecules—ATP1A3—Parkinson's disease	0.0119	0.0148	CbGpPWpGaD
Triamterene—SCNN1G—Transmembrane transport of small molecules—TRPM7—Parkinson's disease	0.0119	0.0148	CbGpPWpGaD
Triamterene—SCNN1D—Transmembrane transport of small molecules—TRPM7—Parkinson's disease	0.0119	0.0148	CbGpPWpGaD
Triamterene—SCNN1D—brain—Parkinson's disease	0.0118	0.063	CbGeAlD
Triamterene—Lamotrigine—ABCB1—Parkinson's disease	0.0112	1	CrCbGaD
Triamterene—SCNN1B—brain—Parkinson's disease	0.00995	0.0533	CbGeAlD
Triamterene—SCNN1A—brain—Parkinson's disease	0.00919	0.0492	CbGeAlD
Triamterene—CYP1A2—Aflatoxin B1 metabolism—GSTM1—Parkinson's disease	0.00709	0.00884	CbGpPWpGaD
Triamterene—SCNN1A—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	0.0063	0.00785	CbGpPWpGaD
Triamterene—SCNN1G—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	0.0063	0.00785	CbGpPWpGaD
Triamterene—SCNN1D—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	0.0063	0.00785	CbGpPWpGaD
Triamterene—SCNN1B—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	0.0063	0.00785	CbGpPWpGaD
Triamterene—CYP1A2—Methylation—COMT—Parkinson's disease	0.00583	0.00727	CbGpPWpGaD
Triamterene—SCNN1G—Transmembrane transport of small molecules—CP—Parkinson's disease	0.0058	0.00723	CbGpPWpGaD
Triamterene—SCNN1B—Transmembrane transport of small molecules—CP—Parkinson's disease	0.0058	0.00723	CbGpPWpGaD
Triamterene—SCNN1D—Transmembrane transport of small molecules—CP—Parkinson's disease	0.0058	0.00723	CbGpPWpGaD
Triamterene—SCNN1A—Transmembrane transport of small molecules—CP—Parkinson's disease	0.0058	0.00723	CbGpPWpGaD
Triamterene—CYP1A2—Fatty Acid Omega Oxidation—CYP2D6—Parkinson's disease	0.00528	0.00658	CbGpPWpGaD
Triamterene—CYP1A2—Fatty Acid Omega Oxidation—CYP2E1—Parkinson's disease	0.00483	0.00602	CbGpPWpGaD
Triamterene—CYP1A2—Xenobiotics—CYP2D6—Parkinson's disease	0.00442	0.00551	CbGpPWpGaD
Triamterene—CYP1A2—Estrogen metabolism—NQO1—Parkinson's disease	0.00434	0.00542	CbGpPWpGaD
Triamterene—CYP1A2—Tamoxifen metabolism—CYP2D6—Parkinson's disease	0.00425	0.0053	CbGpPWpGaD
Triamterene—SCNN1B—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.00413	0.00515	CbGpPWpGaD
Triamterene—SCNN1D—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.00413	0.00515	CbGpPWpGaD
Triamterene—SCNN1A—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.00413	0.00515	CbGpPWpGaD
Triamterene—SCNN1G—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.00413	0.00515	CbGpPWpGaD
Triamterene—CYP1A2—Xenobiotics—CYP2E1—Parkinson's disease	0.00404	0.00504	CbGpPWpGaD
Triamterene—SCNN1G—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.00396	0.00494	CbGpPWpGaD
Triamterene—SCNN1D—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.00396	0.00494	CbGpPWpGaD
Triamterene—SCNN1B—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.00396	0.00494	CbGpPWpGaD
Triamterene—SCNN1A—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.00396	0.00494	CbGpPWpGaD
Triamterene—CYP1A2—Tamoxifen metabolism—CYP2E1—Parkinson's disease	0.00388	0.00484	CbGpPWpGaD
Triamterene—CYP1A2—Estrogen metabolism—COMT—Parkinson's disease	0.00364	0.00454	CbGpPWpGaD
Triamterene—CYP1A2—Tryptophan metabolism—DDC—Parkinson's disease	0.00363	0.00452	CbGpPWpGaD
Triamterene—SCNN1D—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	0.00345	0.0043	CbGpPWpGaD
Triamterene—SCNN1B—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	0.00345	0.0043	CbGpPWpGaD
Triamterene—SCNN1A—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	0.00345	0.0043	CbGpPWpGaD
Triamterene—SCNN1G—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	0.00345	0.0043	CbGpPWpGaD
Triamterene—CYP1A2—Estrogen metabolism—GSTM1—Parkinson's disease	0.00333	0.00415	CbGpPWpGaD
Triamterene—SCNN1D—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	0.00331	0.00412	CbGpPWpGaD
Triamterene—SCNN1G—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	0.00331	0.00412	CbGpPWpGaD
Triamterene—SCNN1A—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	0.00331	0.00412	CbGpPWpGaD
Triamterene—SCNN1B—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	0.00331	0.00412	CbGpPWpGaD
Triamterene—CYP1A2—Melatonin metabolism and effects—CYP2D6—Parkinson's disease	0.00328	0.00409	CbGpPWpGaD
Triamterene—CYP1A2—Tryptophan metabolism—MAOB—Parkinson's disease	0.00305	0.00381	CbGpPWpGaD
Triamterene—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—Parkinson's disease	0.00264	0.00329	CbGpPWpGaD
Triamterene—CYP1A2—Melatonin metabolism and effects—MAOA—Parkinson's disease	0.00247	0.00308	CbGpPWpGaD
Triamterene—CYP1A2—Melatonin metabolism and effects—EDN1—Parkinson's disease	0.0023	0.00287	CbGpPWpGaD
Triamterene—CYP1A2—Tryptophan metabolism—CYP2E1—Parkinson's disease	0.00207	0.00259	CbGpPWpGaD
Triamterene—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—Parkinson's disease	0.00206	0.00257	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor—NQO1—Parkinson's disease	0.00205	0.00256	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor Pathway—NQO1—Parkinson's disease	0.00205	0.00256	CbGpPWpGaD
Triamterene—CYP1A2—Phase II conjugation—GSTA4—Parkinson's disease	0.00204	0.00254	CbGpPWpGaD
Triamterene—CYP1A2—Phase 1 - Functionalization of compounds—MAOB—Parkinson's disease	0.002	0.00249	CbGpPWpGaD
Triamterene—CYP1A2—Melatonin metabolism and effects—APOE—Parkinson's disease	0.00187	0.00233	CbGpPWpGaD
Triamterene—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2D6—Parkinson's disease	0.00183	0.00229	CbGpPWpGaD
Triamterene—CYP1A2—Oxidation by Cytochrome P450—CYP2D6—Parkinson's disease	0.00181	0.00226	CbGpPWpGaD
Triamterene—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2E1—Parkinson's disease	0.00168	0.00209	CbGpPWpGaD
Triamterene—CYP1A2—Oxidation by Cytochrome P450—CYP2E1—Parkinson's disease	0.00166	0.00206	CbGpPWpGaD
Triamterene—CYP1A2—Phase 1 - Functionalization of compounds—CYP2D6—Parkinson's disease	0.00149	0.00185	CbGpPWpGaD
Triamterene—CYP1A2—Arachidonic acid metabolism—GPX1—Parkinson's disease	0.00141	0.00176	CbGpPWpGaD
Triamterene—CYP1A2—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	0.00136	0.0017	CbGpPWpGaD
Triamterene—CYP1A2—Biological oxidations—GSTA4—Parkinson's disease	0.00119	0.00149	CbGpPWpGaD
Triamterene—CYP1A2—Metapathway biotransformation—GSTA4—Parkinson's disease	0.00118	0.00147	CbGpPWpGaD
Triamterene—CYP1A2—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	0.00112	0.00139	CbGpPWpGaD
Triamterene—CYP1A2—Biological oxidations—MAOB—Parkinson's disease	0.00106	0.00132	CbGpPWpGaD
Triamterene—CYP1A2—Phase II conjugation—COMT—Parkinson's disease	0.00102	0.00128	CbGpPWpGaD
Triamterene—CYP1A2—Phase II conjugation—GSTP1—Parkinson's disease	0.00102	0.00127	CbGpPWpGaD
Triamterene—CYP1A2—Phase II conjugation—GSTM1—Parkinson's disease	0.000936	0.00117	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—Parkinson's disease	0.000825	0.00103	CbGpPWpGaD
Triamterene—CYP1A2—Biological oxidations—CYP2D6—Parkinson's disease	0.00079	0.000985	CbGpPWpGaD
Triamterene—CYP1A2—Metapathway biotransformation—CYP2D6—Parkinson's disease	0.000779	0.000971	CbGpPWpGaD
Triamterene—CYP1A2—Biological oxidations—CYP2E1—Parkinson's disease	0.000722	0.000901	CbGpPWpGaD
Triamterene—CYP1A2—Metapathway biotransformation—CYP2E1—Parkinson's disease	0.000712	0.000888	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—GBA—Parkinson's disease	0.00066	0.000823	CbGpPWpGaD
Triamterene—CYP1A2—Biological oxidations—COMT—Parkinson's disease	0.000598	0.000746	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor—TNF—Parkinson's disease	0.000598	0.000746	CbGpPWpGaD
Triamterene—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—Parkinson's disease	0.000598	0.000746	CbGpPWpGaD
Triamterene—CYP1A2—Biological oxidations—GSTP1—Parkinson's disease	0.000596	0.000743	CbGpPWpGaD
Triamterene—CYP1A2—Biological oxidations—MAOA—Parkinson's disease	0.000594	0.000741	CbGpPWpGaD
Triamterene—CYP1A2—Metapathway biotransformation—COMT—Parkinson's disease	0.00059	0.000736	CbGpPWpGaD
Triamterene—CYP1A2—Metapathway biotransformation—GSTP1—Parkinson's disease	0.000587	0.000732	CbGpPWpGaD
Triamterene—CYP1A2—Biological oxidations—GSTM1—Parkinson's disease	0.000547	0.000682	CbGpPWpGaD
Triamterene—CYP1A2—Metapathway biotransformation—GSTM1—Parkinson's disease	0.00054	0.000673	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	0.000412	0.000514	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—ND3—Parkinson's disease	0.000388	0.000484	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—MCCC1—Parkinson's disease	0.000388	0.000484	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—OMD—Parkinson's disease	0.000365	0.000455	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—TALDO1—Parkinson's disease	0.000365	0.000455	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—NDUFB11—Parkinson's disease	0.000346	0.000431	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—GCH1—Parkinson's disease	0.00033	0.000411	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	0.000298	0.000371	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—GBA—Parkinson's disease	0.000294	0.000367	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—FBP1—Parkinson's disease	0.000294	0.000367	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—DBH—Parkinson's disease	0.000294	0.000367	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—DDC—Parkinson's disease	0.000216	0.000269	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—GSTA4—Parkinson's disease	0.000204	0.000254	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	0.000201	0.000251	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—PLA2G6—Parkinson's disease	0.000184	0.000229	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—MAOB—Parkinson's disease	0.000182	0.000227	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	0.000173	0.000216	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—CYP2D6—Parkinson's disease	0.000135	0.000168	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—CTGF—Parkinson's disease	0.000133	0.000165	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—CYP2E1—Parkinson's disease	0.000124	0.000154	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—NQO1—Parkinson's disease	0.000122	0.000152	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—TH—Parkinson's disease	0.00012	0.00015	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—CYCS—Parkinson's disease	0.000116	0.000144	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—COMT—Parkinson's disease	0.000102	0.000128	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—GSTP1—Parkinson's disease	0.000102	0.000127	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—MAOA—Parkinson's disease	0.000102	0.000127	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—HMOX1—Parkinson's disease	0.0001	0.000125	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—ABCB1—Parkinson's disease	9.64e-05	0.00012	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—GSTM1—Parkinson's disease	9.36e-05	0.000117	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—GPX1—Parkinson's disease	8.96e-05	0.000112	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—MTHFR—Parkinson's disease	8.27e-05	0.000103	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—APOE—Parkinson's disease	7.7e-05	9.6e-05	CbGpPWpGaD
Triamterene—CYP1A2—Metabolism—INS—Parkinson's disease	6.58e-05	8.2e-05	CbGpPWpGaD
